News
George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...
Tidmarsh, an adjunct professor at Stanford’s medical school, brings decades of industry experience to the table. Serving as ...
Protalix BioTherapeutics Inc., a biopharmaceutical company, has appointed Gilad Mamlok as Senior Vice President and Chief ...
BIOCON BIOLOGICS GLOBAL PLCDL-NOTES 2024 (24/29) REG.S (USG11185AA61) - All master data, key figures and real-time diagram.
1d
MyChesCo on MSNUniquity Bio Taps Industry Veteran Will Kane as CEO Amid Late-Stage Drug Development PushMALVERN, PA — Uniquity Bio has named Will Kane as its new President and Chief Executive Officer, a move aimed at strengthening the company’s position as it advances its lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results